Equity Briefing: NFL's John Elway scheduled to pitch Neptune during CNBC and Fox Business News interviews

Shares of Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT) (NTB.TO) were up over 7% and rising in anticipation of two news features scheduled for national television on Thursday. Canada's Howard Group is reporting that Celebrity Neptune Krill Oil(TM) endorser and football legend John Elway will appear on CNBC at 4:40pm ET today...

Shares of Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT) (NTB.TO) were up over 7% and rising in anticipation of two news features scheduled for national television on Thursday.

Canada's Howard Group is reporting that Celebrity Neptune Krill Oil(TM) endorser and football legend John Elway will appear on CNBC at 4:40pm ET today. Tune in and watch him talk about his personal experience with Neptune Krill Oil(TM) and Neptune Technologies, the company that pioneered the krill oil Omega 3 phenomenon.

Elway is currently in New York John Elway speaking at SupplySide MarketPlace as a proponent of Omega3s and Ambassador of Neptune Krill Oil(TM).  This marks his first public appearance as an ambassador for the company since the announcement of the partnership on March 27.

Omega 3 Marine Phospholipids supplements are among the most popular dietary supplements on the market and are backed by a growing body of science showing a range of health benefits. In addition to growing consumer health markets for Krill Oil in cardiovascular, inflammatory and neurological diseases, the firm is now sponsoring clinical trials through subsidiaries Acasti Pharma (APO.V) and NeuroBioPharm. Those trails aim to demonstrate product health benefits and to obtain regulatory approval for label health claims in multiple multi-billion dollar markets.
Copyright Thomson Reuters


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: %s via Thomson Reuters ONE


[HUG#1611214]